{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:57:54Z","timestamp":1787587074958,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC1308303"],"award-info":[{"award-number":["2017YFC1308303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873522"],"award-info":[{"award-number":["81873522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Doxorubicin (DOX)-induced cardiotoxicity is a highly concerning issue, and the mechanism by which DOX induces cardiotoxicity is likely to be multifactorial. NADPH oxidase (NOX) is associated with DOX-induced cardiotoxicity. Setanaxib (GKT137831), a preferential direct inhibitor of NOX1 and NOX4, can delay or prevent the progression of many cardiovascular disorders by inhibiting reactive oxygen species (ROS) generation. In this study, we investigated the role of GKT137831 in ameliorating DOX-induced cardiotoxicity and the potential mechanisms of its action.<\/jats:p><jats:p><jats:bold>Methods and Results:<\/jats:bold> The mice model of cardiotoxicity induced by DOX was established, and GKT137831 treatment was performed at the same time. Neonatal rat cardiomyocytes (NRCMs) were treated with DOX or GKT137831 for <jats:italic>in vitro<\/jats:italic> experiments. We found that DOX administration impaired cardiac function <jats:italic>in vivo<\/jats:italic>, reflected by decreased left ventricular ejection fraction (LVEF) and fractional shortening (FS%). DOX also impaired the viability of NRCMs <jats:italic>in vitro<\/jats:italic>. In addition, DOX increased the levels of NOX1 and NOX4 expression and ROS production and the cardiomyocyte apoptosis rate, both <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic>. GKT137831 improved cardiac function, as indicated by the increased LVEF and FS%. <jats:italic>In vitro,<\/jats:italic> GKT137831 improved NRCM viability. It also decreased ROS production and the cardiomyocyte apoptosis rate. Apoptotic indices, such as cleaved PARP (c-PARP), cleaved caspase 3 (CC3) and BAX expression levels, were decreased, and the antiapoptotic index of Bcl-2 expression was increased. DOX markedly activated phosphorylated JNK, ERK and p38 proteins in NRCMs. Specific inhibitors of JNK (SP600125), ERK (PD98059) or p38 (SB203580) inhibited DOX-induced apoptosis of NRCMs. GKT137831 pretreatment inhibited excessive DOX-induced MAPK pathway activation.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> This study revealed that GKT137831 can alleviate DOX-induced cardiomyocyte apoptosis by inhibiting NOX1\/4-driven ROS production. The upregulation of MAPK pathway induced by NOX1\/4-derived ROS production may be the potential mechanism of GKT137831 action. GKT137831 may be a potential drug candidate to ameliorate DOX-induced cardiotoxicity.<\/jats:p>","DOI":"10.3389\/fphar.2022.823975","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:51:45Z","timestamp":1649062305000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Setanaxib (GKT137831) Ameliorates Doxorubicin-Induced Cardiotoxicity by Inhibiting the NOX1\/NOX4\/Reactive Oxygen Species\/MAPK Pathway"],"prefix":"10.3389","volume":"13","author":[{"given":"Hui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1007\/s00018-012-1010-9","article-title":"The NOX Toolbox: Validating the Role of NADPH Oxidases in Physiology and Disease","volume":"69","author":"Altenhofer","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10565-006-0140-y","article-title":"Adriamycin-induced Oxidative Mitochondrial Cardiotoxicity","volume":"23","author":"Berthiaume","year":"2007","journal-title":"Cell Biol Toxicol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.3892\/mmr.2020.11521","article-title":"Protective Effects of Valsartan Administration on Doxorubicin-induced Myocardial Injury in Rats and the Role of Oxidative Stress and NOX2\/NOX4 Signaling","volume":"22","author":"Cheng","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/s0021-9258(17)35746-0","article-title":"Redox Cycling of Anthracyclines by Cardiac Mitochondria. I. Anthracycline Radical Formation by NADH Dehydrogenase","volume":"261","author":"Davies","year":"1986","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.freeradbiomed.2006.11.013","article-title":"Gp91phox-containing NAD(P)H Oxidase Increases Superoxide Formation by Doxorubicin and NADPH","volume":"42","author":"Deng","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/cvr\/cvs026","article-title":"Endothelial-specific Nox2 Overexpression Increases Vascular Superoxide and Macrophage Recruitment in ApoE\u207b\/\u207b Mice","volume":"94","author":"Douglas","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/164_2020_387","article-title":"NOX Inhibitors: from Bench to Naxibs to Bedside","volume":"264","author":"Elbatreek","year":"2021","journal-title":"Handb Exp. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40263-020-00787-5","article-title":"Inhibitors of Src Family Kinases, Inducible Nitric Oxide Synthase, and NADPH Oxidase as Potential CNS Drug Targets for Neurological Diseases","volume":"35","author":"Gage","year":"2021","journal-title":"CNS Drugs"},{"key":"B9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.bbrc.2009.08.085","article-title":"NADPH Oxidases Participate to Doxorubicin-Induced Cardiac Myocyte Apoptosis","volume":"388","author":"Gilleron","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0005-2736(86)90374-3","article-title":"Mechanism of Inhibition of Mitochondrial Enzymatic Complex I-III by Adriamycin Derivatives","volume":"861","author":"Goormaghtigh","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0301-4622(90)80012-v","article-title":"Structure of the Adriamycin-Cardiolipin Complex. Role in Mitochondrial Toxicity","volume":"35","author":"Goormaghtigh","year":"1990","journal-title":"Biophys. Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"F1276","DOI":"10.1152\/ajprenal.00396.2014","article-title":"Targeting NADPH Oxidase with a Novel Dual Nox1\/Nox4 Inhibitor Attenuates Renal Pathology in Type 1 Diabetes","volume":"308","author":"Gorin","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.112.132159","article-title":"NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus-Accelerated Atherosclerosis","volume":"127","author":"Gray","year":"2013","journal-title":"Circulation"},{"key":"B14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00125-015-3796-0","article-title":"Podocyte-specific Nox4 Deletion Affords Renoprotection in a Mouse Model of Diabetic Nephropathy","volume":"59","author":"Jha","year":"2016","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s13205-020-02377-0","article-title":"MAPK Enzymes: a ROS Activated Signaling Sensors Involved in Modulating Heat Stress Response, Tolerance and Grain Stability of Wheat under Heat Stress","volume":"10","author":"Kumar","year":"2020","journal-title":"3 Biotech."},{"key":"B16","doi-asserted-by":"publisher","first-page":"748524","DOI":"10.1155\/2014\/748524","article-title":"Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction","volume":"2014","author":"Li","year":"2014","journal-title":"Oxid. Med. Cel Longev."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01949-2019","article-title":"NADPH Oxidase DUOX1 Sustains TGF-\u03b21 Signalling and Promotes Lung Fibrosis","volume":"57","author":"Louzada","year":"2021","journal-title":"Eur. Respir. J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/cvr\/cvs309","article-title":"Rac1 Signalling Mediates Doxorubicin-Induced Cardiotoxicity through Both Reactive Oxygen Species-dependent and -independent Pathways","volume":"97","author":"Ma","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.redox.2015.06.012","article-title":"Regulation of Nox Enzymes Expression in Vascular Pathophysiology: Focusing on Transcription Factors and Epigenetic Mechanisms","volume":"5","author":"Manea","year":"2015","journal-title":"Redox Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline Chemotherapy and Cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1111\/bph.13773","article-title":"Signalling Mechanisms Underlying Doxorubicin and Nox2 NADPH Oxidase-Induced Cardiomyopathy: Involvement of Mitofusin-2","volume":"174","author":"McLaughlin","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1016\/j.bbamcr.2016.09.012","article-title":"Activation of Apoptosis Signalling Pathways by Reactive Oxygen Species","volume":"1863","author":"Redza-Dutordoir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2011.02.028","article-title":"Role for Nox1 NADPH Oxidase in Atherosclerosis","volume":"216","author":"Sheehan","year":"2011","journal-title":"Atherosclerosis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1056\/NEJM199809243391307","article-title":"Doxorubicin-induced Cardiomyopathy","volume":"339","author":"Singal","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"792639","DOI":"10.1155\/2011\/792639","article-title":"Mitogen-activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?","volume":"2011","author":"Son","year":"2011","journal-title":"J. Signal. Transduct."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1111\/j.1742-4658.2008.06488.x","article-title":"Structure, Regulation and Evolution of Nox-Family NADPH Oxidases that Produce Reactive Oxygen Species","volume":"275","author":"Sumimoto","year":"2008","journal-title":"FEBS J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1089\/ars.2018.7583","article-title":"Vascular Biology of Superoxide-Generating NADPH Oxidase 5-implications in Hypertension and Cardiovascular Disease","volume":"30","author":"Touyz","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"B28","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":"Risk Factors for Doxorubicin-Induced Congestive Heart Failure","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann. Intern. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","article-title":"NAD(P)H Oxidase and Multidrug Resistance Protein Genetic Polymorphisms Are Associated with Doxorubicin-Induced Cardiotoxicity","volume":"112","author":"Wojnowski","year":"2005","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.biopha.2018.11.077","article-title":"Nox1\/4 Dual Inhibitor GKT137831 Attenuates Hypertensive Cardiac Remodelling Associating with the Inhibition of ADAM17-dependent Proinflammatory Cytokines-Induced Signalling Pathways in the Rats with Abdominal Artery Constriction","volume":"109","author":"Zeng","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"101523","DOI":"10.1016\/j.redox.2020.101523","article-title":"NLRP3 Inflammasome-Mediated Pyroptosis Contributes to the Pathogenesis of Non-ischemic Dilated Cardiomyopathy","volume":"34","author":"Zeng","year":"","journal-title":"Redox Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1078365","DOI":"10.1155\/2020\/1078365","article-title":"Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1\/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1\/2","volume":"2020","author":"Zeng","year":"","journal-title":"Mediators Inflamm."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the Molecular Basis of Doxorubicin-Induced Cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"9287","DOI":"10.1158\/0008-5472.CAN-10-2664","article-title":"Nox2 NADPH Oxidase Promotes Pathologic Cardiac Remodeling Associated with Doxorubicin Chemotherapy","volume":"70","author":"Zhao","year":"2010","journal-title":"Cancer Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.114.011079","article-title":"NADPH Oxidase 4 Induces Cardiac Fibrosis and Hypertrophy through Activating Akt\/mTOR and NF\u03baB Signaling Pathways","volume":"131","author":"Zhao","year":"2015","journal-title":"Circulation"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.823975\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:51:49Z","timestamp":1649062309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.823975\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":35,"alternative-id":["10.3389\/fphar.2022.823975"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.823975","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"article-number":"823975"}}